Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namenda in pathological gambling
NCT00585169Phase 2Completed
- Sponsor
- Yale University
- Start
- Dec 2007
- Primary completion
- Dec 2011
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in gambling disorder (GD), sponsored by Yale University. Started Dec 2007; status: completed.
02
Drugs
memantine
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT00585169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585169.